Medindia LOGIN REGISTER
Medindia
Advertisement

Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis

Tuesday, November 24, 2009 General News
Advertisement

Contacts:

Cephalon:

Media:

Investor Relations:

Sheryl Williams

Chip Merritt

610-738-6493 (office)

610-738-6376 (office)

610-457-5257 (cell)

[email protected]

[email protected]

Ception:

Media: Mike Beyer - Sam Brown Inc.

773-463-4211 (office)

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close